MDUFA V: FDA Looks For More User-Fee Investments; Industry Wants To Work With What’s There
Executive Summary
US FDA commissioner Stephen Hahn argued on 27 October that his device center should consider more user-fee investments to alleviate the agency’s workload and address new innovations – but industry wants the FDA to finish hiring and work with what’s there.
You may also be interested in...
Virtual FDA-Industry MDUFA Negotiations To Kick Off After Months Of Delay
The US FDA and industry stakeholders are set to finally start monthly user fee negotiations online by February. The process has already been significantly delayed due to the pandemic and recent holidays.
US Election 2020: What Does A Trump Or Biden Win Mean For FDA Regulations?
Experts say either would likely prioritize issues such as the coronavirus pandemic and the medical supply chain, but they would diverge in areas like laboratory developed test reform.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.